Galmed gains 5% after securing three new U.S. patents for Aramchol and meglumine salt
11 Janeiro 2022 - 10:31AM
Seeking Alpha
To read the full story on Seeking Alpha, click
here.
Galmed Pharmaceuticals (NASDAQ:GLMD)
Gráfico Histórico do Ativo
De Fev 2024 até Mar 2024
Galmed Pharmaceuticals (NASDAQ:GLMD)
Gráfico Histórico do Ativo
De Mar 2023 até Mar 2024